SOLIGENIX, INC. Stock Issued During Period, Shares, Reverse Stock Splits
SOLIGENIX, INC. (SNGX) had Stock Issued During Period, Shares, Reverse Stock Splits of 0 shares as of 2024-06-05, per its 10-K filed 2025-03-21.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits · last filed 2025-03-21
- 2024-06-05: Stock Issued During Period, Shares, Reverse Stock Splits 0.00 shares.
| Period end | Stock Issued During Period, Shares, Reverse Stock Splits |
|---|---|
| 2024-06-05 | 0.00 shares 10-K · filed 2025-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |